Joint Nordic Procurement of Pharmaceuticals — 2022 — NF2.603.a

AMGROS I/S

Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. Under this procurement group, the pharmaceuticals are tendered under each procurement no. for the purpose of supplying the Contracting Authorities as 2 markets (Norway as 1 market and Denmark and Iceland as 1 market) see section II.2.4 and the tender specification.
The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.

Deadline

Fristen for modtagelse af bud var på 2021-08-31. Indkøbet blev offentliggjort på 2021-06-09.

Leverandører

Følgende leverandører er nævnt i tildelingsbeslutninger eller andre indkøbsdokumenter:

Hvem? Hvad? Hvor?
Indkøbshistorik
Dato Dokument
2021-06-09 Udbudsbekendtgørelse
2021-12-20 Bekendtgørelse om indgåede kontrakter
Udbudsbekendtgørelse (2021-06-09)
Objekt
Omfanget af udbuddet
Titel: Lægemidler
Kort beskrivelse:
Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. Under this procurement group, the pharmaceuticals are tendered under each procurement no. for the purpose of supplying the Contracting Authorities as 2 markets (Norway as 1 market and Denmark and Iceland as 1 market) see section II.2.4 and the tender specification. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.
Vis mere
Bekendtgørelsens metadata
Originalsprog: engelsk 🗣️
Dokumenttype: Udbudsbekendtgørelse
Kontraktens art: Varer
Forordning: Den Europæiske Union, med deltagelse af GPA-lande
Fælles glossar for offentlige kontrakter (CPV)
Kode: Lægemidler 📦
Yderligere CPV-kode: Lægemidler 📦
Sted for udførelsen
NUTS-region: Danmark 🏙️

Procedure
Procedureform: Offentligt udbud
Bud-type: Indsendelse gældende for alle delaftaler
Kriterier for tildeling
Det økonomisk mest fordelagtige bud

Ordregivende myndighed
Identitet
Land: Danmark 🇩🇰
Type af ordregivende myndighed: Offentligretligt organ
Navn på ordregivende myndighed: Amgros I/S
Postadresse: Dampfærgevej 22
Postnummer: 2100
Postby: København Ø
Kontakt
Internetadresse: http://www.amgros.dk 🌏
E-mail: udbud@amgros.dk 📧
Telefon: +45 88713000 📞
Fax: +45 88713008 📠
URL til dokumenter: http://www.amgros.dk 🌏

Reference
Datoer
Afsendelsesdato: 2021-06-09 📅
Tilbudsfrist: 2021-08-31 📅
Offentliggørelsesdato: 2021-06-14 📅
Startdato: 2022-04-01 📅
Slutdato: 2024-03-31 📅
Identifikatorer
Bekendtgørelsesnummer: 2021/S 113-296265
EUT-S-nummer: 113
Yderligere oplysninger
The tenderers are not permitted to attend the opening of the tenders. Tenders will be registered upon receipt, and tenders received on time will be opened collectively after expiry of the deadline for submission of tenders. With the notice regarding the tender evaluation, the tenderers will receive a comprehensive overview of the operators that have submitted compliant tenders.
Vis mere

Objekt
Omfanget af udbuddet
Kort beskrivelse:
Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. Under this procurement group, the pharmaceuticals are tendered under each procurement no. for the purpose of supplying the Contracting Authorities as 2 markets (Norway as 1 market and Denmark and Iceland as 1 market) see section II.2.4 and the tender specification.
Vis mere
The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.
Vis mere
Anslået samlet værdi: 8 000 000 EUR 💰
Delkontraktens titel: 1
Delkontraktnummer: 1
Kort beskrivelse:
ATC Code: A04AA01
Generic Name: Ondansetrone
Pharmaceutical form: Injection Fluid
Strenght: 2 mg/ml
Package: 2 ml
Unit: 16 mg
Volume in units: (Denmark 186.598) (Iceland 10)
Package: 4 ml
Volume in units: (Denmark 17.010) (Iceland 6.493)
Each procurement number is a separate lot for the pharmaceutical indicated and is put up for tender independently of the other procurement numbers. This means that a tenderer may submit a tender for one, several or all procurement numbers (lots), and that framework agreements will be awarded separately for each procurement number. However, the aim is to conclude framework agreements with different suppliers for the procurement numbers 1 and 2, which are linked procurement numbers.
Vis mere
If there is only one compliant tender for either procurement numbers 1 or 2, the framework agreement for the procurement number in question is awarded to the supplier concerned. The supplier concerned will then be excluded from award on the other of the two procurement numbers, and the framework agreement will be awarded to the supplier of the remaining suppliers offering the “best price-quality ra-tio”.
Vis mere
If there are several compliant tenders for both procurement numbers 1 and 2, the award under pro-curement number 1 will take precedence. This means that if the same supplier has submitted a tender offering the “best price-quality ratio” for both procurement numbers 1 and 2, and there are several com-pliant tenders for both procurement numbers 1 and 2, the Contracting Authorities will only award the supplier concerned a framework agreement for procurement number 1, since the framework agreement for procurement number 2 is awarded to the supplier with the “second best price-quality ratio” under the procurement number concerned.
Vis mere
If there is only one compliant tender for both procurement numbers 1 and 2, the framework agreements will be awarded to the suppliers of the respective compliant tenders, notwithstanding that this may mean that the same supplier will be awarded a framework agreement for both procurement numbers 1 and 2.
Vis mere
For every single pharmaceutical, a maximum price has been determined (price per unit ex. VAT) stated in Appendix A. Tenders with prices that exceed the set maximum price will be considered non-compliant and will not be able to form a basis for conclusion of framework agreement, see the tender specifications section 10.3
Vis mere
Under the title "quantity in units", an estimated consumption of the pharmaceuticals is indicated for each of the countries. It should be noted that this estimate corresponds to the historical consumption of the pharmaceuticals put up for tender and that suppliers must expect that the actual purchase under a framework agreement may deviate significantly from the estimate. Reference is made to paragraph 5.6 of the tender specifications and clause 4.2 in the framework agreement.
Vis mere
The Supplier must have authorisation to produce, import or receive pharmaceuticals for wholesale distribution within the EU/EEA.
The Pharmaceuticals shall be included in the Danish Medicines Agency’s list of medicine prices (“medicinpriser.dk”), the Norwegian "Farmalogg" and the Icelandic “Lyfjaverðskrá” not later than 21 February 2022 in order to ensure supply from the beginning of the Purchase Period.
Vis mere
The framework agreements are non-exclusive to the supplier. The hospitals and health authorities are not obliged to use the framework agreement.
Anslået værdi uden moms: 790 400 EUR 💰
Beskrivelse af fornyelser:
The contracting authorities shall be entitled to extend the framework agreement up to 2 times for each pharmaceutical on unchanged terms and conditions by up to 12 months.
Beskrivelse af mulighederne:
Clause 8.2 of the framework agreement provides for an option for delivery in a pre-agreement period (i.e. before the purchase period begins) and an option for delivery in a post-agreement period (i.e. after the purchase period). The two options may be exercised on the terms and conditions stipulated in the framework agreement.
Vis mere
Delkontraktens titel: 2
Delkontraktnummer: 2
Kort beskrivelse:
Volume in units: Norway 110.000
Volume in units: Norway 13.000
Anslået værdi uden moms: 949 000 EUR 💰
Beskrivelse af fornyelser:
The Contracting Authorities shall be entitled to extend the framework agreement up to 2 times for each pharmaceutical on unchanged terms and conditions by up to 12 months.
Delkontraktens titel: 3
Delkontraktnummer: 3
Kort beskrivelse:
ATC Code: J01DC02
Generic Name: Cefuroxime
Strenght: 250 mg
Package: Vial
Unit: 3 g
Volume in units: Norway 4.722
Anslået værdi uden moms: 900 EUR 💰
Delkontraktens titel: 4
Delkontraktnummer: 4
Kort beskrivelse: Volume in units: (Denmark 1.016) (Iceland 10)
Delkontraktens titel: 5
Delkontraktnummer: 5
Kort beskrivelse:
Strenght: 750 mg
Volume in units: (Denmark 48.690) (Iceland 520)
Strenght: 1500 mg
Volume in units: (Denmark 349.540) (Iceland 1.550)
Anslået værdi uden moms: 1 004 000 EUR 💰
Delkontraktens titel: 6
Delkontraktnummer: 6
Kort beskrivelse:
Volume in units: Norway 7.480
Volume in units: Norway 10
Anslået værdi uden moms: 143 400 EUR 💰
Delkontraktens titel: 7
Delkontraktnummer: 7
Kort beskrivelse:
ATC Code: N02BE01
Generic Name: Paracetamole
Pharmaceutical form: Infusion Fluid
Strenght: 10 mg/ml
Package: 10-50 ml
Volume in units: Norway 2.667
Package: 100 ml
Volume in units: Norway 583.333
Anslået værdi uden moms: 130 300 EUR 💰
Delkontraktens titel: 8
Delkontraktnummer: 8
Kort beskrivelse:
Volume in units: (Denmark 2.611) (Iceland 10)
Volume in units: (Denmark 230.190) (Iceland 166.666)
Anslået værdi uden moms: 53 300 EUR 💰
Delkontraktens titel: 9
Delkontraktnummer: 9
Kort beskrivelse:
ATC Code: L01BA01
Generic Name: Methotrexate
Pharmaceutical form: Conc. Infusion Fluid
Strenght: 100 mg/ml
Package: 10 ml
Unit: 11,42 mg
Volume in units: Norway 245.184
Package: 50 ml
Volume in units: Norway 1.444.834
Anslået værdi uden moms: 644 100 EUR 💰
Delkontraktens titel: 10
Delkontraktnummer: 10
Kort beskrivelse:
Volume in units: (Denmark 144.370) (Iceland 875)
Volume in units: (Denmark 775.222) (Iceland 43.782)
Anslået værdi uden moms: 240 900 EUR 💰

Juridiske, økonomiske, finansielle og tekniske oplysninger
Betingelser for deltagelse
Egnethed til at udøve det erhverv:
When submitting a tender, suppliers must use the European Single Procurement Document (ESPD) in the tendering system for the declaration regarding the compulsory grounds for exclusion set out in sections 135-136 of the Danish Public Procurement Act (udbudsloven) (the Act can be found at www.retsinformation.dk). Further information on the completion and application of the ESPD in the tender process is available in the guide drawn up by Amgros in this respect and in the ‘Instructions for the European Single Procurement Document’ drawn up by the Danish Competition and Consumer Authority (Konkurrence- og Forbrugerstyrelsen). The successful tenderer(s) to whom the contracting authorities intend to award the framework agreement must also, before the award, provide documentation to the contracting authorities regarding the absence of compulsory grounds for exclusion as set out in sections 152-153 of the Public Procurement Act. The contracting authorities are not entitled to exclude a supplier who is subject to one or more of the mandatory exclusion grounds set out in sections 135-136 of the Public Procurement Act if the supplier has provided sufficient documentation that the supplier is reliable, even if the supplier is subject to one or more of the grounds for exclusion set out in section 138 of the Public Procurement Act. The contracting authorities reserve the right to carry out a so-called ‘self-cleaning’ process if relevant.
Vis mere
Kontraktens udførelse
Betingelser for opfyldelse af kontrakten:
Reference is made to the provisions of the draft framework agreement and section II.2.4).
No specific legal form is required. If the contract is awarded to a group of suppliers, each participant must undertake joint and several liability and appoint a joint representative.

Procedure
Retsgrundlag: 32014L0024
Gældende udbudslovgivning: Danish law
Tidspunkt for modtagelse af tilbud: 12:00
Sprog, på hvilke bud eller ansøgninger om deltagelse kan indgives: dansk 🗣️
engelsk 🗣️
+ 2 mere norsk 🗣️
svensk 🗣️
Dato for åbning af tilbud: 2021-08-31 📅
Tidspunkt for åbning af tilbud: 12:00
Sted: Amgros I/S, Dampfærgevej 27-29, DK-2100 Copenhagen Ø.
Yderligere oplysninger:
The tenderers are not permitted to attend the opening of the tenders. Tenders will be registered upon receipt, and tenders received on time will be opened collectively after expiry of the deadline for submission of tenders. With the notice regarding the tender evaluation, the tenderers will receive a comprehensive overview of the operators that have submitted compliant tenders.
Vis mere

Ordregivende myndighed
Identitet
Navn på ordregivende myndighed: Landspítali Háskólasjúkrahús
Postadresse: Skaftahlíð 24
Postby: Reykavik
Postnummer: 105
Land: Island 🇮🇸
Navn på ordregivende myndighed: Sykehusinnkjøp HF, divisjon legemidler
Postadresse: Grev Wedels Plass 7 5. etasje
Postby: Oslo
Postnummer: 0151
Land: Norge 🇳🇴
Kontakt
Enhed: Flemming Sonne
Hulda Harðardóttir
E-mail: huldahar@landspitali.is 📧
Internetadresse: http://www.rikiskaup.is/ 🌏
Enhed: Eirik Sverrisson
E-mail: legemidler@sykehusinnkjop.no 📧
Internetadresse: http://www.sykehusinnkjop.no 🌏
URL til dokumenter: www.amgros.dk 🌏
URL til dokumenter: www.amgros.dk 🌏

Reference
Yderligere oplysninger
This call for tenders is conducted as an open procedure in accordance with the Danish Procurement Act (udbudsloven). The procurement procedure is subject to Danish law and any complaints of the procurement procedure shall be lodged with the Danish Complaints Board for Public Procurement (Klagenævnet for udbud),see section VI.4.3.
Vis mere
In relation to section II.2.4, it should be noted, that the Contracting Authorities have considered whether the procurement group could be further subdivided. The contracting authorities have deemed that this is not the case based on the considerations of economies of scale, which will not be realizable with a further subdivision as well as costs and patient safety considerations related to the subsequent management of contract- and pharmaceuticals.
Vis mere
In relation to sections II.1.5) and II.2.6) it should be noted that the estimated value indicated in section II.1.5) is the total estimated value of all procurement numbers (lots) for the duration of the framework agreement, including the option of renewal, see section II.2.7). Section II.2.6) sets out the estimated value for each procurement number, including the option of renewal, see section II.2.7. The value is based on the AIP (‘Apotekernes Indkøbspris’ published by the Danish Medicines Agency) of the pharmaceuticals. It should furthermore be noted that the estimated value is based on historic consumption data and that the actual purchase under a framework agreement may deviate significantly from the estimate, see section II.2.4), paragraph 5.6 of the tender specifications and clause 4.2 of the framework agreement.
Vis mere
Questions concerning the tender documents must be submitted through the tendering system, see the provisions of the tender specifications in this regard.
The access to submit tender requires that the operator is registered as a user of Amgros' tendering system. The registration as a user may take a few days, and the tenderer must therefore make sure to register in good time. Reference is made to the information provided in the tendering system, including the user guide.
Vis mere
In relation to section VI.2 it should be noted that electronic invoicing is required.

Supplerende oplysninger
Gennemgå organ
Navn: Klagenævnet for Udbud
Postadresse: Nævnenes Hus, Toldboden 2
Postby: Viborg
Postnummer: 8800
Land: Danmark 🇩🇰
Telefon: +45 72405600 📞
E-mail: klfu@naevneneshus.dk 📧
Internetadresse: https://klfu.naevneneshus.dk 🌏
Oplysninger om frister for klageprocedurer:
Pursuant to the Danish Act on the Complaints Board for Public Procurement (Act no. 593 of 2 June 2016 as amended) the following deadlines apply to the lodging of complaints:
Complaints of the tendering procedure must be lodged with the Complaints Board for Public Procurement within 6 months after the contracting entity has entered into a framework agreement calculated from the day after the day when the contracting entity has notified the affected applicants and tenderers, see section 7(2), para.(3) of the Act. Not later than at the time of lodging a complaint with the Danish Complaints Board for Public Procurement, the complainant must notify the contracting authorities in writing that a complaint has been lodged with the Danish Complaints Board for Public Procurement and whether the complaint was lodged during the standstill period, see section 6(4) of the Act. In cases where the complaint was not lodged within the standstill period, the complainant must furthermore indicate whether a suspensory effect of the complaint has been requested, see clause 6(4) of the Act.
Vis mere
Tjeneste, hvorfra der kan indhentes oplysninger om klageproceduren
Navn: Konkurrence- og Forbrugerstyrelsen
Postadresse: Carl Jacobsens vej 35
Postby: Valby
Postnummer: 2500
Telefon: +45 41715000 📞
Internetadresse: http://www.kfst.dk 🌏
Kilde: OJS 2021/S 113-296265 (2021-06-09)
Bekendtgørelse om indgåede kontrakter (2021-12-20)
Objekt
Omfanget af udbuddet
Den samlede værdi af udbuddet: 6 500 000 EUR 💰
Bekendtgørelsens metadata
Dokumenttype: Bekendtgørelse om indgåede kontrakter

Procedure
Bud-type: Finder ikke anvendelse

Reference
Datoer
Afsendelsesdato: 2021-12-20 📅
Offentliggørelsesdato: 2021-12-24 📅
Identifikatorer
Bekendtgørelsesnummer: 2021/S 250-660819
Henviser til bekendtgørelse: 2021/S 113-296265
EUT-S-nummer: 250
Yderligere oplysninger
This call for tenders is conducted as an open procedure in accordance with the Danish Procurement Act (udbudsloven). The procurement procedure is subject to Danish law and any complaints of the procurement procedure shall be lodged with the Danish Complaints Board for Public Procurement (Klagenævnet for udbud),see section VI.4.3. In relation to section II.2.4, it should be noted, that the Contracting Authorities have considered wheth-er the procurement group could be further subdivided. The Contracting Authorities have deemed that this is not the case based on the considerations of economies of scale, which will not be realizable with a further subdivision as well as costs and patient safety considerations related to the subsequent man-agement of contract- and pharmaceuticals. In relation to sections II.1.5 and II.2.6 it should be noted that the estimated value indicated in section II.1.5 is the total estimated value of all procurement numbers (lots) for the duration of the framework agreement, including the option of renewal, see section II.2.7. Section II.2.6 sets out the estimated value for each procurement number, including the option of renewal, see section II.2.7. The value is based on the AIP ("Apotekernes Indkøbspris" published by the Danish Medicines Agency) of the pharmaceuticals. It should furthermore be noted that the estimated value is based on historic consumption data and that the actual purchase under a framework agreement may deviate significantly from the estimate, see section II.2.4, paragraph 5.6 of the tender specifications and clause 4.2 of the framework agreement. Questions concerning the tender documents must be submitted through the tendering system, see the provisions of the tender specifications in this regard. The access to submit tender requires that the operator is registered as a user of Amgros' tendering system. The registration as a user may take a few days, and the tenderer must therefore make sure to register in good time. Reference is made to the information provided in the tendering system, including the user guide. In relation to section VI.2 it should be noted that electronic invoicing is required.
Vis mere

Procedure
Kriterier for tildeling
Kvalitetskriterium (navn): Security of Supply
Kvalitetskriterium (vægtning): 20
Kvalitetskriterium (navn): Environment
Kvalitetskriterium (vægtning): 30
Pris (justeringskoefficient): 50
Kvalitetskriterium (navn): Security of supply
Securiyt of Supply
Enviromnent
security of supply
Evironment
environment

Tildeling af kontrakt
Dato for kontraktindgåelse: 2021-12-14 📅
Navn: Fresenius Kabi
Nationalt registreringsnummer: 21347809
Postby: Copenhagen S
Postnummer: 2300
Land: Danmark 🇩🇰
Danmark 🏙️
Den samlede værdi af udbuddet: 330 000 EUR 💰
Navn: Life Medical ApS
Nationalt registreringsnummer: 32560946
Postby: Måløv
Postnummer: 2670
Den samlede værdi af udbuddet: 985 000 EUR 💰
Navn: Navamedic AB
Postby: Göteborg
Postnummer: 433 63
Land: Sverige 🇸🇪
Den samlede værdi af udbuddet: 113 000 EUR 💰
Navn: Navamedic
Den samlede værdi af udbuddet: 95 000 EUR 💰
1 310 000 EUR 💰
Navn: Navemedic
Den samlede værdi af udbuddet: 90 025 EUR 💰
Navn: B Braun Medical A/S
Nationalt registreringsnummer: 20343249
Postby: Frederiksberg
Postnummer: 2000
Den samlede værdi af udbuddet: 1 370 000 EUR 💰
Navn: Baxter A/S
Nationalt registreringsnummer: 72246012
Postby: Søborg
Postnummer: 2860
Den samlede værdi af udbuddet: 1 300 000 EUR 💰
Navn: Sandoz A/S
Nationalt registreringsnummer: 27744532
Den samlede værdi af udbuddet: 334 000 EUR 💰
425 000 EUR 💰
Oplysninger om udbud
Antal modtagne bud: 2
1
3

Reference
Yderligere oplysninger
In relation to section II.2.4, it should be noted, that the Contracting Authorities have considered wheth-er the procurement group could be further subdivided. The Contracting Authorities have deemed that this is not the case based on the considerations of economies of scale, which will not be realizable with a further subdivision as well as costs and patient safety considerations related to the subsequent man-agement of contract- and pharmaceuticals.
Vis mere
In relation to sections II.1.5 and II.2.6 it should be noted that the estimated value indicated in section II.1.5 is the total estimated value of all procurement numbers (lots) for the duration of the framework agreement, including the option of renewal, see section II.2.7. Section II.2.6 sets out the estimated value for each procurement number, including the option of renewal, see section II.2.7. The value is based on the AIP ("Apotekernes Indkøbspris" published by the Danish Medicines Agency) of the pharmaceuticals. It should furthermore be noted that the estimated value is based on historic consumption data and that the actual purchase under a framework agreement may deviate significantly from the estimate, see section II.2.4, paragraph 5.6 of the tender specifications and clause 4.2 of the framework agreement.
Vis mere
Kilde: OJS 2021/S 250-660819 (2021-12-20)
Nye indkøb inden for beslægtede kategorier 🆕
Relaterede søgninger 🔍
Region:
Danmark Danmark
Leverandører:
B Braun Medical A/S Baxter A/S Fresenius Kabi Life Medical ApS Navamedic AB Navamedic Navemedic Sandoz A/S
Produkter/tjenester:
Medicinsk udstyr, lægemidler og produkter... Lægemidler